SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-049521
Filing Date
2018-09-14
Accepted
2018-09-14 16:30:59
Documents
1
Period of Report
2018-09-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv502882_4.html 4  
1 OWNERSHIP DOCUMENT tv502882_4.xml 4 4656
  Complete submission text file 0001144204-18-049521.txt   6262
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 SNUNIT STREET SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address
Naos Yaron (Reporting) CIK: 0001742727 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 181071487